The pharmaceutical community is intrigued by retatrutide, a novel dual GIP and GLP-1 agonist that’s showing impressive results in clinical studies . This compound works by imitating natural hormones to impact appetite and increase feelings of satisfaction , ultimately leading substantial weight loss . While presently under investigation and not y